Skip Nav Destination
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study
Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo
The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants
Issue Archive
October 9 2014
In this Issue
Table of Contents
INSIDE BLOOD COMMENTARIES
PLENARY PAPER
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
Clinical Trials & Observations
Giovanni Palladini,Ute Hegenbart,Paolo Milani,Christoph Kimmich,Andrea Foli,Anthony D. Ho,Marta Vidus Rosin,Riccardo Albertini,Remigio Moratti,Giampaolo Merlini,Stefan Schönland
BLOOD SPOTLIGHT
REVIEW ARTICLE
Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study
Clinical Trials & Observations
Smita Bhatia,Wendy Landier,Lindsey Hageman,Heeyoung Kim,Yanjun Chen,Kristine R. Crews,William E. Evans,Bruce Bostrom,Jacqueline Casillas,David S. Dickens,Kelly W. Maloney,Joseph P. Neglia,Yaddanapudi Ravindranath,A. Kim Ritchey,F. Lennie Wong,Mary V. Relling
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
Clinical Trials & Observations
Adam M. Petrich,Mitul Gandhi,Borko Jovanovic,Jorge J. Castillo,Saurabh Rajguru,David T. Yang,Khushboo A. Shah,Jeremy D. Whyman,Frederick Lansigan,Francisco J. Hernandez-Ilizaliturri,Lisa X. Lee,Stefan K. Barta,Shruthi Melinamani,Reem Karmali,Camille Adeimy,Scott Smith,Neil Dalal,Chadi Nabhan,David Peace,Julie Vose,Andrew M. Evens,Namrata Shah,Timothy S. Fenske,Andrew D. Zelenetz,Daniel J. Landsburg,Christina Howlett,Anthony Mato,Michael Jaglal,Julio C. Chavez,Judy P. Tsai,Nishitha Reddy,Shaoying Li,Caitlin Handler,Christopher R. Flowers,Jonathon B. Cohen,Kristie A. Blum,Kevin Song,Haowei (Linda) Sun,Oliver Press,Ryan Cassaday,Jesse Jaso,L. Jeffrey Medeiros,Aliyah R. Sohani,Jeremy S. Abramson
HEMATOPOIESIS AND STEM CELLS
UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity
Marie-Eve Bordeleau,Romain Aucagne,Jalila Chagraoui,Simon Girard,Nadine Mayotte,Éric Bonneil,Pierre Thibault,Caroline Pabst,Anne Bergeron,Frédéric Barabé,Josée Hébert,Martin Sauvageau,Christel Boutonnet,Sylvain Meloche,Guy Sauvageau
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis
Esther Rodríguez-Díez,Victor Quereda,Florian Bellutti,Michaela Prchal-Murphy,David Partida,Manuel Eguren,Karoline Kollmann,Marta Gómez de Cedrón,Pierre Dubus,Marta Cañamero,Dolores Martínez,Veronika Sexl,Marcos Malumbres
MYELOID NEOPLASIA
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report
Fabiana Ostronoff,Megan Othus,Robert B. Gerbing,Michael R. Loken,Susana C. Raimondi,Betsy A. Hirsch,Beverly J. Lange,Stephen Petersdorf,Jerald Radich,Frederick R. Appelbaum,Alan S. Gamis,Todd A. Alonzo,Soheil Meshinchi
Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study
Brief Report
Frédéric Millot,Joelle Guilhot,André Baruchel,Arnaud Petit,Yves Bertrand,Françoise Mazingue,Patrick Lutz,Cecile Vérité,Christian Berthou,Claire Galambrun,Nicolas Sirvent,Karima Yakouben,Claudine Schmitt,Virginie Gandemer,Yves Reguerre,Gérard Couillault,Françoise Mechinaud,Jean-Michel Cayuela
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo
e-blood
Asif J. Iqbal,Eileen McNeill,Theodore S. Kapellos,Daniel Regan-Komito,Sophie Norman,Sarah Burd,Nicola Smart,Daniel E. W. Machemer,Elena Stylianou,Helen McShane,Keith M. Channon,Ajay Chawla,David R. Greaves
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
BLOOD WORK
CORRESPONDENCE
The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants
Clinical Trials & Observations
Ayalew Tefferi,Terra L. Lasho,Alexander Tischer,Emnet A. Wassie,Christy M. Finke,Alem A. Belachew,Rhett P. Ketterling,Curtis A. Hanson,Animesh D. Pardanani
ERRATA
-
Cover Image
Cover Image
Immunofluorescence microscopy of E12.5 yolk sac of a CD68-GFP transgenic mouse embryo. Monocytes and macrophages express the GFP reporter gene driven by the human CD68 promoter. Costaining with PECAM-1 shows close association between endothelial cells (red) and macrophages (green) in the developing vasculature. Nuclei are stained blue with the DNA dye DAPI. See the article by Iqbal et al on page e33.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals